Status:

COMPLETED

Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

Sandler Family Supporting Foundation

Conditions:

Asthma

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The purpose of this study is to determine whether an inhaled corticosteroid (fluticasone) alters the expression of any gene expressed in the lining of the airways of asthmatics. The study uses high de...

Detailed Description

This is a 10 week, randomized, double blind, prospective study comparing the effects of inhaled fluticasone or inhaled placebo on measures of airway function, airway remodeling and airway gene express...

Eligibility Criteria

Inclusion

  • Male and female patients with a history of asthma between the ages of 18 and 70 years.
  • PC20FEV1 Methacholine ≤ 8.0 mg/mL.
  • At least one of the following symptoms, beta agonist use, or FEV1 criteria:
  • Asthma symptoms on at least two days per week or Beta agonist use on at least two days per week or FEV1 \< 85% predicted
  • Subjects must be non-smokers (patients who have never smoked or patients who have not smoked for 1 year and have a total pack-year smoking history \< 15 packs).

Exclusion

  • History of oral or inhaled steroid use in the past 4 weeks.
  • FEV1 \< 60% predicted.
  • Lung disease other than asthma.
  • Patients with a history of a respiratory tract infection in the 4 weeks preceding the study.
  • Patients who have experienced a significant exacerbation in their asthma in the 6 weeks prior to the study.
  • Patients receiving hyposensitization therapy with the exception of those who are on a stable dose for the last three months.
  • Patients with cardiovascular disease (active) peptic ulcer disease or diabetes mellitus.
  • Females who are lactating or who are pregnant.

Key Trial Info

Start Date :

October 1 2002

Trial Type :

INTERVENTIONAL

End Date :

February 1 2005

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00187499

Start Date

October 1 2002

End Date

February 1 2005

Last Update

April 3 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Airway Clinical Research Center, Room 1303 Moffitt, UCSF Medical Center

San Francisco, California, United States, 94143